InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS [Yahoo! Finance]
InspireMD Inc. (NSPR)
NASDAQ:AMEX Investor Relations:
inspiremd.com/en/investors/investor-relations
Company Research
Source: Yahoo! Finance
The CE Mark certification under the MDR regulatory framework replaces the previous MDR framework, which controlled the approval and marketing of medical devices in the EU until May 2021. Price Performance For the past six months, NSPR's shares have declined 8.7% against the industry's growth of 1.5%. The S&P 500 increased 9.6% in the same time frame. Image Source: Zacks Investment Research More on the News With the official recertification of the CE Mark under MDR, the company is likely to proceed with the establishment of the CGuard Embolic Prevention Carotid Stent System (EPS) as the standard care for carotid artery revascularization. The company also looks forward to advancing new products using the pathway provided by MDR. The company is making good progress on the Premarket Approval Application (PMA) for the C-GUARDIANS U.S. IDE study. It anticipates receiving the primary endpoint results in mid-2024, and in the second half of 2024, the company is likely to submit th
Show less
Read more
Impact Snapshot
Event Time:
NSPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NSPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NSPR alerts
High impacting InspireMD Inc. news events
Weekly update
A roundup of the hottest topics
NSPR
News
- InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- InspireMD, Inc. (NYSE: NSPR) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- InspireMD to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year [Yahoo! Finance]Yahoo! Finance
NSPR
Sec Filings
- 4/25/24 - Form SC
- 4/18/24 - Form ARS
- 4/18/24 - Form DEFA14A
- NSPR's page on the SEC website